MICROMED CO., LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. Concept Prototyping
2. Technology Actualization
3. Product Commercialization
4. Incubation
2. Technology Actualization
3. Product Commercialization
4. Incubation
The content above was translated by Ai
Founded Year
2016
Unified Business No.
43800235
Status
Active
Number of Employees
11
Total Paid-in
Capital
35,535,657 (NT$)
Location of Company
Taiwan
, New Taipei City
Overseas Development
Denmark、United States of America
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
MicroMED is a MEMS design house specializing in the development of microinjection devices targeting unmet needs in the most challenging drug delivery applications. MicroMED has established a proprietary high-precision MEMS drug delivery engine system, capable of delivering broad flow rate from 1 nL/min to 10 mL/min with driving force upto 2,000 atm (29,000 psi) of pressure.
MicroMED welcomes all types of business connections/relations in the PDA drug delivery value chain (pharma, biotech, medical injector developer and insurance payer) with the goals below (but not limited to):
• Purchasing of the current micro-engine products • Co-development of advanced injector products • Licensing of the micro-engine proprietaries/intellectual properties.
MicroMED welcomes all types of business connections/relations in the PDA drug delivery value chain (pharma, biotech, medical injector developer and insurance payer) with the goals below (but not limited to):
• Purchasing of the current micro-engine products • Co-development of advanced injector products • Licensing of the micro-engine proprietaries/intellectual properties.
The content above was translated by Ai
Corporate Video
